Aug 24, 2022 08:00 AM

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd.’s Net Profit Dropped 68.2% in First Half of 2022

By Caixin Automation

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd. (通化金马药业集团股份有限公司) (000766.SZ) reported a net profit of 7.1 million yuan in the first half of 2022, down 68.2% year-on-year.

Meanwhile, the company posted 693.7 million yuan in revenue, down 11.6% year-on-year.

At the end of the reporting period, it had 4.6 billion yuan in total assets and 2.3 billion yuan in total liabilities, with a liability-to-asset ratio of 49.2%.

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Innovation Takes Off at Flying Vehicle Expo

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

Caixin Deep Dive: How China’s Crypto Ban Makes Disposing of Seized Assets a Lot Harder

00:00

00:00/00:00

MOST POPULAR

1: Cover Story: China’s Factory Exodus Is Turning Vietnam Into the World’s Assembler

2: Meituan Enters Open-Source AI Race With LongCat Model

3: Ex-UBS Banker in Hong Kong Jailed 10 Years for Laundering $17.2 Million

4: Saudi Power Giant ACWA Bets Big on China’s Renewable Energy Market

5: End of U.S. Tax Exemption Hits Chinese Air Cargo Carriers Differently

SPONSORED

OR